Division of Infectious Diseases Launches Clinical Studies to Uncover COVID-19 Treatments

Daniel Kaul, MD and Kevin Gregg, MD lead clinical trials to determine whether Remdesivir and Sarilumab could be safe and effective treatments for patients with COVID-19.